Literature DB >> 9820373

Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation.

M L Cravo1, C M Albuquerque, L Salazar de Sousa, L M Glória, P Chaves, A Dias Pereira, C Nobre Leitão, M G Quina, F Costa Mira.   

Abstract

OBJECTIVE: Microsatellite instability (MSI) detected in non-neoplastic mucosa of patients with ulcerative colitis has been ascribed to an excess of DNA damage associated with chronic inflammation. Folate deficiency, commonly found in patients with long-standing disease, could further contribute to this defect because folate is essential for DNA replication and repair. We evaluated MSI in the colonic mucosa of 26 patients with ulcerative colitis for >10 yr and 10 patients with Crohn's colitis and correlated MSI with folate status.
METHODS: DNA was amplified using primers directed at nine different loci. Folate concentrations in serum, whole blood, and colonic mucosa were determined using the Lactobacillus casei assay.
RESULTS: MSI was found in 3/23 patients (13%) with ulcerative colitis and in none of the patients with Crohn's colitis. All three patients with MSI had inactive histological disease, whereas all patients with active disease were negative for MSI (p = 0.08). Serum, whole blood, and colonic concentrations of folate were 30-50% lower in patients with MSI (p > 0.05), and folate supplements had been administered less frequently during the past 5-yr (p = 0.06). One of the patients with MSI was randomized to receive folate 5 mg/d for 6 months, and a clear change in MSI pattern was observed in three of six markers.
CONCLUSIONS: A defect in DNA repair associated with a low folate status may be one additional cause for patients with ulcerative colitis exhibiting MSI in non-neoplastic mucosa.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820373     DOI: 10.1111/j.1572-0241.1998.00592.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

1.  Genetic instability and the mutator phenotype. Studies in ulcerative colitis.

Authors:  K R Loeb; L A Loeb
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 2.  Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis.

Authors:  Susan J Duthie
Journal:  J Inherit Metab Dis       Date:  2010-06-11       Impact factor: 4.982

Review 3.  Folate and fiber in the prevention of colorectal cancer: between shadows and the light.

Authors:  Wan Du; Wen-Ying Li; Rong Lu; Jing-Yuan Fang
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

4.  Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers.

Authors:  L Cawkwell; F Sutherland; H Murgatroyd; P Jarvis; S Gray; D Cross; N Shepherd; D Day; P Quirke
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

5.  Microsatellite instability in inflamed and neoplastic epithelium in ulcerative colitis.

Authors:  T Ishitsuka; H Kashiwagi; F Konishi
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

6.  Folate deficiency alters hepatic and colon MGMT and OGG-1 DNA repair protein expression in rats but has no effect on genome-wide DNA methylation.

Authors:  Susan J Duthie; George Grant; Lynn P Pirie; Amanda J Watson; Geoffrey P Margison
Journal:  Cancer Prev Res (Phila)       Date:  2010-01

7.  The risk of colorectal cancer in patients with ulcerative colitis.

Authors:  Tobias M Nowacki; Markus Brückner; Maria Eveslage; Phil Tepasse; Friederike Pott; Nils H Thoennissen; Karin Hengst; Matthias Ross; Dominik Bettenworth
Journal:  Dig Dis Sci       Date:  2014-10-04       Impact factor: 3.199

8.  In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis.

Authors:  A Goel; A Mittal; R Evstatiev; M Nemeth; W Kruis; M Stolte; C R Boland; C Gasche
Journal:  Aliment Pharmacol Ther       Date:  2009-06-25       Impact factor: 8.171

9.  Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer.

Authors:  Hamed Khalili; Jian Gong; Hermann Brenner; Thomas R Austin; Carolyn M Hutter; Yoshifumi Baba; John A Baron; Sonja I Berndt; Stéphane Bézieau; Bette Caan; Peter T Campbell; Jenny Chang-Claude; Stephen J Chanock; Constance Chen; Li Hsu; Shuo Jiao; David V Conti; David Duggan; Charles S Fuchs; Manish Gala; Steven Gallinger; Robert W Haile; Tabitha A Harrison; Richard Hayes; Aditi Hazra; Brian Henderson; Chris Haiman; Michael Hoffmeister; John L Hopper; Mark A Jenkins; Laurence N Kolonel; Sébastien Küry; Andrea LaCroix; Loic Le Marchand; Mathieu Lemire; Noralane M Lindor; Jing Ma; JoAnn E Manson; Teppei Morikawa; Hongmei Nan; Kimmie Ng; Polly A Newcomb; Reiko Nishihara; John D Potter; Conghui Qu; Robert E Schoen; Fredrick R Schumacher; Daniela Seminara; Darin Taverna; Stephen Thibodeau; Jean Wactawski-Wende; Emily White; Kana Wu; Brent W Zanke; Graham Casey; Thomas J Hudson; Peter Kraft; Ulrike Peters; Martha L Slattery; Shuji Ogino; Andrew T Chan
Journal:  Carcinogenesis       Date:  2015-06-12       Impact factor: 4.741

10.  Genetic alterations in ulcerative colitis-associated neoplasia focusing on APC, K-ras gene and microsatellite instability.

Authors:  N Umetani; S Sasaki; T Watanabe; M Shinozaki; K Matsuda; H Ishigami; E Ueda; T Muto
Journal:  Jpn J Cancer Res       Date:  1999-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.